Knott David M Jr Aadi Bioscience, Inc. Transaction History

Knott David M Jr

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$4.84 - $7.13 $19,360 - $28,520	4,000 Added 1.53%	265,000 $1.28 Million
Q2 2023 Aug 11, 2023	BUY	$6.84 - $8.56 $528,814 - $661,790	77,312 Added 42.09%	261,000 $1.79 Million
Q1 2023 May 11, 2023	BUY	$6.85 - $13.0 $1.07 Million - $2.03 Million	156,446 Added 574.28%	183,688 $1.33 Million
Q4 2022 Feb 13, 2023	SELL	$11.99 - $14.5 $261,346 - $316,056	-21,797 Reduced 44.45%	27,242 $350,000
Q3 2022 Nov 10, 2022	BUY	$12.03 - $14.22 $421,050 - $497,700	35,000 Added 249.31%	49,039 $693,000
Q2 2022 Aug 11, 2022	BUY	$11.57 - $17.92 $162,431 - $251,578	14,039 New	14,039 $173,000

15.6M

15K

3.1K

Ticker AADI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,016,800
Market Cap $40.1M
Description
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

Stay updated on Knott David M Jr with notifications on news.